Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

06/11/2019 04:30

Nov 6 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             45.17               47.52            92.90    
                 (-4.9 pct)          (-4.7 pct)       (-1.3 pct)  
  Operating         13.74               12.36            22.30    
                 (+11.2 pct)         (-19.4 pct)      (-9.3 pct)  
  Recurring         13.93               12.54            22.70    
                 (+11.1 pct)         (-19.2 pct)      (-9.1 pct)  
  Net                9.55                8.84            16.10    
                 (+8.0 pct)          (-18.7 pct)      (-9.4 pct)  
  EPS            242.56 yen          220.84 yen       413.69 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T